FDA Watch: Off-Label Marketing Rule Put Back on Ice & Extra Comment Time for CLIA Waiver Proposals
From - Laboratory Industry Report For the second time in less than a year, the FDA indefinitely delayed a controversial rule expanding its authority to regulate off-label marketing… . . . read more
This content is exclusive to Lab Industry Report subscribers
Start a Free Triall for immediate access to this article and our entire archive of over 20 years of LIR reports.